journal article·2026-02Open access

Photosensitizing Lipid Nanoparticles for Ferroptosis‐Enhanced Photodynamic Cancer Therapy via GPX4 Silencing

Ga‐Hyun Bae, Seungyong Shin, Joo Dong Park, Eun‐Young Koh, Seunghyo Ko, Jieun Han, Chun Gown Park, Dong‐Hyun Kim, Kun Na, Wooram Park

Advanced Healthcare Materials· Volume 15· Issue 7

Abstract

Abstract Ferroptosis, a regulated form of non‐apoptotic cell death driven by iron‐dependent lipid peroxidation, has emerged as a promising approach for overcoming therapy‐resistant cancers. A multifunctional lipid nanoparticle (LNP) platform was developed to integrate ferroptosis induction with photodynamic therapy (PDT) for synergistic anticancer effects. By partially substituting cholesterol in conventional DLin‐MC3‐DMA (MC3)‐based LNPs with cholesterol—polyethylene glycol (PEG)–pheophorbide a (CPP), we engineered photosensitizing lipid nanoparticles (PLNPs) capable of delivering glutathione peroxidase 4 (GPX4)‐targeting small interfering RNA (siRNA). Upon laser irradiation, the PLNPs generate reactive oxygen species (ROS) through PDT, while siRNA‐mediated GPX4 silencing promotes ferroptosis by disrupting cellular antioxidant defenses. The PLNPs demonstrate favorable physicochemical characteristics, efficient gene silencing, and potent ROS production. In vitro experiments in 4T1 and EO771 breast cancer cells reveal enhanced cytotoxicity under combined treatment, underscoring the synergistic interaction between PDT‐induced oxidative stress and ferroptotic cell death. In vivo, the PLNPs exhibit prolonged tumor retention, effective GPX4 knockdown, and significant tumor growth inhibition, with minimal systemic toxicity. Overall, this work introduces a dual‐function nanoplatform that potentiates photodynamic cancer therapy through ferroptosis induction and offers a versatile strategy for developing next‐generation combination treatments targeting aggressive tumors.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Ferroptosis and cancer prognosis · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of MetaBioHealth Institute for Cross‐disciplinary Studies (ICS) Sungkyunkwan University (SKKU) Seobu‐ro 2066 Suwon Gyeonggi 16419 Republic of Korea

Department of Integrative Biotechnology College of Biotechnology and Bioengineering, SKKU Seobu‐ro 2066 Suwon Gyeonggi 16419 Republic of Korea

Department of Biomedical Engineering ICS, SKKU Seobu‐ro 2066 Suwon Gyeonggi 16419 Republic of Korea

Department of Radiology Feinberg School of Medicine Northwestern University Chicago IL 60611 USA

Robert H. Lurie Comprehensive Cancer Center Northwestern University Chicago IL 60611 USA

Department of Biomedical Engineering McCormick School of Engineering Northwestern University Evanston IL 60208 USA

Department of Biomedical‐Chemical Engineering The Catholic University of Korea Jibong‐ro 43 Bucheon Gyeonggi 14662 Republic of Korea

Department of Biotechnology The Catholic University of Korea Jibong‐ro 43 Bucheon Gyeonggi 14662 Republic of Korea

Funding

Korea Basic Science Institute · National Research Foundation of Korea

References (64)

Show source-provided references
1. 10.18632/aging.20250210.18632/aging.202502 ↗
2. 10.3322/caac.2166010.3322/caac.21660 ↗
3. 10.1038/s41392-023-01606-110.1038/s41392-023-01606-1 ↗
4. 10.1002/adfm.20240715310.1002/adfm.202407153 ↗
5. 10.1016/j.biomaterials.2024.12279310.1016/j.biomaterials.2024.122793 ↗
6. 10.1016/j.ccell.2019.04.00210.1016/j.ccell.2019.04.002 ↗
7. 10.1038/s41420-022-01212-010.1038/s41420-022-01212-0 ↗
8. 10.1126/scitranslmed.adg304910.1126/scitranslmed.adg3049 ↗
9. 10.1002/adhm.20220308510.1002/adhm.202203085 ↗
10. 10.1016/j.mtbio.2024.10105310.1016/j.mtbio.2024.101053 ↗
11. 10.3322/caac.2119910.3322/caac.21199 ↗
12. 10.1186/s12943-022-01696-510.1186/s12943-022-01696-5 ↗
13. 10.1016/j.biomaterials.2025.12341110.1016/j.biomaterials.2025.123411 ↗
14. 10.1038/s41565-019-0591-y10.1038/s41565-019-0591-y ↗
15. 10.1038/nbt.160210.1038/nbt.1602 ↗
16. 10.1038/s41467-021-26714-w10.1038/s41467-021-26714-w ↗
17. 10.1038/s41578-021-00358-010.1038/s41578-021-00358-0 ↗
18. 10.7150/thno.11247510.7150/thno.112475 ↗
19. 10.1016/j.jconrel.2022.05.05610.1016/j.jconrel.2022.05.056 ↗
20. 10.3389/fchem.2015.0003310.3389/fchem.2015.00033 ↗
21. 10.1016/j.biopha.2021.11130210.1016/j.biopha.2021.111302 ↗
22. 10.3390/ijms22191050610.3390/ijms221910506 ↗
23. 10.1002/adhm.20250072610.1002/adhm.202500726 ↗
24. 10.7150/thno.5303110.7150/thno.53031 ↗
25. 10.1016/j.biomaterials.2025.12310610.1016/j.biomaterials.2025.123106 ↗
26. 10.1016/j.biomaterials.2022.12144910.1016/j.biomaterials.2022.121449 ↗
27. 10.1002/anie.20220542910.1002/anie.202205429 ↗
28. 10.1016/j.heliyon.2024.e2497310.1016/j.heliyon.2024.e24973 ↗
29. 10.3390/cancers1520504310.3390/cancers15205043 ↗
30. 10.1002/adfm.20250360410.1002/adfm.202503604 ↗
31. 10.1016/j.biomaterials.2018.08.05210.1016/j.biomaterials.2018.08.052 ↗
32. 10.1007/s10337-022-04143-110.1007/s10337-022-04143-1 ↗
33. Ó’Fágáin C. · 2010
34. 10.1038/s41596-022-00755-x10.1038/s41596-022-00755-x ↗
35. 10.1016/j.biomaterials.2013.05.01710.1016/j.biomaterials.2013.05.017 ↗
36. 10.1002/adma.20231379110.1002/adma.202313791 ↗
37. 10.1021/acsami.9b2332510.1021/acsami.9b23325 ↗
38. 10.1002/adfm.20231572110.1002/adfm.202315721 ↗
39. 10.1002/adhm.20240481910.1002/adhm.202404819 ↗
40. 10.1016/j.apsb.2024.03.00410.1016/j.apsb.2024.03.004 ↗
41. 10.1039/D3RA04074G10.1039/D3RA04074G ↗
42. 10.1002/adfm.20250049110.1002/adfm.202500491 ↗
43. 10.1038/s41419-020-2298-210.1038/s41419-020-2298-2 ↗
44. 10.1002/smll.20240316510.1002/smll.202403165 ↗
45. 10.1038/s41419-023-06045-y10.1038/s41419-023-06045-y ↗
46. 10.21769/BioProtoc.312810.21769/BioProtoc.3128 ↗
47. 10.1038/cddis.2012.17110.1038/cddis.2012.171 ↗
48. 10.1038/s41467-019-09566-310.1038/s41467-019-09566-3 ↗
49. 10.1016/j.biomaterials.2024.12291410.1016/j.biomaterials.2024.122914 ↗
50. 10.1038/s41420-022-01297-710.1038/s41420-022-01297-7 ↗
51. 10.1021/acs.nanolett.9b0290410.1021/acs.nanolett.9b02904 ↗
52. 10.1002/adfm.20241813810.1002/adfm.202418138 ↗
53. 10.1002/0471142735.im2002s3910.1002/0471142735.im2002s39 ↗
54. 10.1242/dmm.05077110.1242/dmm.050771 ↗
55. 10.3389/fonc.2020.0119510.3389/fonc.2020.01195 ↗
56. 10.1016/j.biopha.2024.11651210.1016/j.biopha.2024.116512 ↗
57. 10.1016/j.freeradbiomed.2020.02.02710.1016/j.freeradbiomed.2020.02.027 ↗
58. 10.1021/acsami.5c0395610.1021/acsami.5c03956 ↗
59. 10.1016/j.biomaterials.2025.12309210.1016/j.biomaterials.2025.123092 ↗
60. 10.1002/anie.20221821810.1002/anie.202218218 ↗
61. 10.1002/ame2.1213910.1002/ame2.12139 ↗
62. 10.1002/adfm.20231354010.1002/adfm.202313540 ↗
63. 10.1016/j.biomaterials.2025.12352510.1016/j.biomaterials.2025.123525 ↗
64. 10.1039/C6CS00271D10.1039/C6CS00271D ↗